Cerebellar Intracerebral Hemorrhage with Intraventricular Extension: A Case Report in a 62-Year-Old Male with Uncontrolled Hypertension
A Case Report
DOI:
https://doi.org/10.33005/jdiversemedres.v2i10.205Keywords:
Hypertension, Intracerebral hemorrhage, Intraventricular hemorrhage, CerebellumAbstract
Intracerebral hemorrhage (ICH) is a subtype of stroke with high morbidity and mortality, where cerebellar location with intraventricular extension (IVH) is a serious condition. Uncontrolled hypertension is a major risk factor that plays a role in the occurrence of ICH. This study is a case report of a 62-year-old man with a history of uncontrolled hypertension who presented with decreased consciousness accompanied by nausea and vomiting. CT scan examination showed left cerebellar hemorrhage measuring ±18.11 cc with extension to the entire ventricular system. The patient was managed conservatively with blood pressure control, intracranial pressure reduction, and supportive therapy. During treatment, the patient experienced improved consciousness, blood pressure stabilization, and neurological function without progressive complications. This case demonstrates that appropriate and comprehensive conservative management can provide good clinical outcomes in patients with cerebellar ICH with IVH extension. This case report emphasizes the importance of early detection, appropriate intervention, and control of risk factors, especially hypertension.
Downloads
References
Rajashekar D, Liang JW. Intracerebral hemorrhage. In: StatPearls [Internet]. StatPearls Publishing; 2023.
Lee TH. Intracerebral Hemorrhage. Cerebrovasc Dis Extra. 2025;15(1):1–8.
Incontri D, Marchina S, Andreev A, Wilson M, Wang JY, Lin D, et al. Etiology of Primary Cerebellar Intracerebral Hemorrhage Based on Topographic Localization. Stroke. 2023;54(12):3074–80.
Wang S, Zou XL, Wu LX, Zhou HF, Xiao L, Yao T, et al. Epidemiology of intracerebral hemorrhage: A systematic review and meta-analysis. Front Neurol. 2022;13:915813.
Wang H, Lin J, Zhao F, Zhang X, Wang L, Zhang C, et al. Burden of Intracerebral Hemorrhage in Asia from 1990 to 2030: A Population-Based Study. Neuroepidemiology. 2025;2025(1):1–20.
An SJ, Kim TJ, Yoon BW. Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update. J Stroke. 2017;19(1):3–10.
Trifan G, Arshi B, Testai FD. Intraventricular Hemorrhage Severity as a Predictor of Outcome in Intracerebral Hemorrhage. Front Neurol. 2019;10:217.
Roeder SS, Sprügel MI, Sembill JA, Giede-Jeppe A, Macha K, Madžar D, et al. Influence of the Extent of Intraventricular Hemorrhage on Functional Outcome and Mortality in Intracerebral Hemorrhage. Cerebrovasc Dis. 2019;47(5–6):245–52.
Essibayi MA, Ibrahim Abdallah O, Mortezaei A, Zaidi SE, Vaishnav D, Cherian J, et al. Natural History, Pathophysiology, and Recent Management Modalities of Intraventricular Hemorrhage. J Intensive Care Med. 2024;39(9):813–9.
Magid-Bernstein J, Girard R, Polster S, Srinath A, Romanos S, Awad IA, et al. Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions. Circulation Research. 2022;130(8):1204–29.
Heit JJ, Iv M, Wintermark M. Imaging of Intracranial Hemorrhage. J Stroke. 2017;19(1):11–27.
Xian Y, Zhang S, Inohara T, Grau-Sepulveda M, Matsouaka RA, Peterson ED, et al. Clinical Characteristics and Outcomes Associated With Oral Anticoagulant Use Among Patients Hospitalized With Intracerebral Hemorrhage. JAMA Netw Open. 2021;4(2):e2037438.
Magid-Bernstein J, Girard R, Polster S, Srinath A, Romanos S, Awad IA, et al. Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions. Circulation Research. 2022;130(8):1204–29.
Irmawati A, Sihombing MR, Darmawan AR, Al Khonsa N, Faizah Balqis N, Zakia F, et al. A Review: Cigarettes Trigger Chronic Inflammation in the Body. International Journal of Advanced Multidisciplinary Research and Studies. 2025;5(3):1337–45.
Cho S, Rehni AK, Dave KR. Tobacco Use: A Major Risk Factor of Intracerebral Hemorrhage. J Stroke. 2021;23(1):37–50.
Svensson EH, Abul-Kasim K, Engström G, Söderholm M. Risk factors for intracerebral haemorrhage – Results from a prospective population-based study. European Stroke Journal. 2020;5(3):278–85.
Gurevitz C, Auriel E, Elis A, Kornowski R. The Association between Low Levels of Low Density Lipoprotein Cholesterol and Intracerebral Hemorrhage: Cause for Concern? JCM. 2022;11(3):536.
Kumar EAA, Nikitha P, Bai PJ. Clinical profile of spontaneous cerebellar hemorrhage - An original article. International Archives of Integrated Medicine. 2023;10(4):1–9.
Lattanzi S, Silvestrini M. Blood pressure in acute intra-cerebral hemorrhage. Ann Transl Med. 2016;4(16):320–320.
Moullaali TJ, Wang X, Martin RH, Shipes VB, Robinson TG, Chalmers J, et al. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data. The Lancet Neurology. 2019;18(9):857–64.
Li Q, Warren AD, Qureshi AI, Morotti A, Falcone GJ, Sheth KN, et al. Ultra‐Early Blood Pressure Reduction Attenuates Hematoma Growth and Improves Outcome in Intracerebral Hemorrhage. Annals of Neurology. 2020;88(2):388–95.
Brown CS, Oliveira J. E Silva L, Mattson AE, Cabrera D, Farrell K, Gerberi DJ, et al. Comparison of Intravenous Antihypertensives on Blood Pressure Control in Acute Neurovascular Emergencies: A Systematic Review. Neurocrit Care. 2022;37(2):435–46.
Soh MS, Won K heon, Kim JJ, Lee SY, Hyon MS, Youn HJ, et al. Phase III randomized clinical trial of efficacy and safety of amlodipine and candesartan cilexetil combination for hypertension treatment. Sci Rep. 2024;14(1):22940.
Kim JH, Jeong H, Choo YH, Kim M, Ha EJ, Oh J, et al. Optimizing Mannitol Use in Managing Increased Intracranial Pressure: A Comprehensive Review of Recent Research and Clinical Experiences. Korean J Neurotrauma. 2023;19(2):162.
Aisyah S, Hasmono D, Muzayyanah B, Agung Ns F. Mannitol Usage Pattern in Hemorrhagic Stroke Patients. Kme. 2023;2023(1):540–8.
Sun S, Li Y, Zhang H, Wang X, She L, Yan Z, et al. The Effect of Mannitol in the Early Stage of Supratentorial Hypertensive Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis. World Neurosurgery. 2019;124:386–96.
Secades Ruiz JJ, Gareri P. Citicolina: revisión farmacológica y clínica, actualización 2022. RevNeurol. 2022;75(S05):S1.
Utomo TY, Nugroho FPW, Yudawijaya A. The Relationship Between Citicoline Administration and the National Institute of Health Stroke Scale in Hemorrhagic Stroke Patients at Dr. Regional General Hospital Chasbullah Abdulmadjid Bekasi City in 2022. Gal Int J Health Sci Res. 2024;9(1):59–71.
Gu Q, Zhu C, Huang J. Risk factors for gastrointestinal bleeding in patients with intracerebral hemorrhage: A propensity score matching analysis. Journal of Clinical Neuroscience. 2024;127:110772.
Daou M, Dionne JC, Teng JFT, Taran S, Zytaruk N, Cook D, et al. Prophylactic acid suppressants in patients with primary neurologic injury: A systematic review and meta-analysis of randomized controlled trials. Journal of Critical Care. 2022;71:154093.
Xu J, Zhang M, Tao L, Zhang S, Tang Z. Ondansetron: A Potential Intervention for Improving Clinical Outcomes in Stroke Patients. Front Pharmacol. 2025;16:2025.
Barbuskaite D, Oernbo EK, Wardman JH, Toft-Bertelsen TL, Conti E, Andreassen SN, et al. Acetazolamide modulates intracranial pressure directly by its action on the cerebrospinal fluid secretion apparatus. Fluids Barriers CNS. 2022;19(1):53.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Diverse Medical Research : Medicosphere
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
